Patents matching “sars-cov-”

WO 2026047603

COMPOSITIONS IMMUNOGÈNES CONTRE SARS-COV-2

BIONTECH SE [DE] · Granted Mar 5, 2026 · Expires Feb 28, 2046

US 20260035439

Anti-Sars-COV-2 Antibodies and Uses Thereof

ABBVIE INC [US] · Granted Feb 5, 2026 · Expires Jan 31, 2046

US 12331078

Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same

The Regents of the University of Colorado, a Body Corporate · Granted Jun 17, 2025 · Expires Jun 12, 2045

US 12251440

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMACEUTICALS, INC. · Granted Mar 18, 2025 · Expires Mar 13, 2045

US 12209142

SARS-CoV-2 epitope-targeted peptide immunostimulants

The United States of America as represented by the Secretary of the Army · Granted Jan 28, 2025 · Expires Jan 23, 2045

US 11999777

Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Jun 4, 2024 · Expires May 30, 2044

US 11993644

Antigen binding molecules targeting SARS-CoV-2

Generate Biomedicines, Inc. · Granted May 28, 2024 · Expires May 23, 2044

WO 2024068265

PARTICULES DE TYPE VIRUS PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 UTILISÉES EN TANT QUE VACCINS DE RAPPEL ET LEURS UTILISATIONS

BAVARIAN NORDIC AS [DK] · Granted Apr 4, 2024 · Expires Mar 30, 2044

US 11866407

Compositions and methods for inhibiting Mpro and PLpro protease activity and for preventing and treating SARS-CoV-2 infection

Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 9, 2024 · Expires Jan 4, 2044

US 11739137

Single domain antibodies to SARS-CoV-2 nucleocapsid protein

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Aug 29, 2023 · Expires Aug 24, 2043

US 11732030

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

WO 2022229817

VACCINS COMPRENANT DES PARTICULES PSEUDO-VIRALES PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 ET LEURS MÉTHODES D'UTILISATION

BAVARIAN NORDIC AS [DK] · Granted Nov 3, 2022 · Expires Oct 29, 2042

US 11479599

Antibodies against SARS-CoV-2 and methods of using the same

Vir Biotechnology, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

US 11168128

Antibodies against SARS-CoV-2 and methods of using the same

Vir Biotechnology, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

US 10975139

Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMACEUTICALS, INC. · Granted Apr 13, 2021 · Expires Apr 8, 2041

US 10954289

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMACEUTICALS, INC. · Granted Mar 23, 2021 · Expires Mar 18, 2041

US 10787501

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMACEUTICALS, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040